Clinical trial

Assessment of the Safety and Efficacy of DERMASTREAM™ - ENZYSTREAM™ System for…

NCT00485329 · EnzySurge, Industry · Completed

Key facts

NCT number NCT00485329
Title Assessment of the Safety and Efficacy of DERMASTREAM™ - ENZYSTREAM™ System for the Treatment of Chronic Venous Ulcers
Official title A Phase I/II Randomized, Double Blind, Placebo-Controlled Dose- Escalating Study, to Assess The Safety and Efficacy of Enzystream™ Debriding Solution (Papain) Applied by Dermastream™ Device for the Treatment of Lower Extremity Chronic Venous Ulcers
Acronym ENZ-DER-002-IL
Lead sponsor EnzySurge, Industry
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Lower Extremity Chronic Venous Ulcers
Intervention type Other
Interventions Papain
Enrollment 48
Start date Jul 1, 2007
Primary completion Mar 1, 2009
Completion Mar 1, 2009
First posted Jun 12, 2007
Last update posted May 25, 2010
Countries Israel

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies